Cargando…
Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194560/ http://dx.doi.org/10.1186/1546-0096-9-S1-P201 |
| _version_ | 1782213999620784128 |
|---|---|
| author | Horneff, G Fitter, S Huppertz, HI Foeldvari, I Kuemmerle-Deschner, K Kuester, R Tzaribacev, N Thon, A Borte, M Ganser, G Trauzeddel, R Minden, K |
| author_facet | Horneff, G Fitter, S Huppertz, HI Foeldvari, I Kuemmerle-Deschner, K Kuester, R Tzaribacev, N Thon, A Borte, M Ganser, G Trauzeddel, R Minden, K |
| author_sort | Horneff, G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3194560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31945602011-10-18 Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab Horneff, G Fitter, S Huppertz, HI Foeldvari, I Kuemmerle-Deschner, K Kuester, R Tzaribacev, N Thon, A Borte, M Ganser, G Trauzeddel, R Minden, K Pediatr Rheumatol Online J Poster Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194560/ http://dx.doi.org/10.1186/1546-0096-9-S1-P201 Text en Copyright ©2011 Horneff et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Horneff, G Fitter, S Huppertz, HI Foeldvari, I Kuemmerle-Deschner, K Kuester, R Tzaribacev, N Thon, A Borte, M Ganser, G Trauzeddel, R Minden, K Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title | Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title_full | Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title_fullStr | Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title_full_unstemmed | Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title_short | Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab |
| title_sort | phase iii, multi-centre, randomised, double blind, placebo-controlled study for treatment of juvenile ankylosing spondylitis (as) with adalimumab |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194560/ http://dx.doi.org/10.1186/1546-0096-9-S1-P201 |
| work_keys_str_mv | AT horneffg phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT fitters phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT huppertzhi phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT foeldvarii phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT kuemmerledeschnerk phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT kuesterr phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT tzaribacevn phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT thona phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT bortem phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT ganserg phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT trauzeddelr phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab AT mindenk phaseiiimulticentrerandomiseddoubleblindplacebocontrolledstudyfortreatmentofjuvenileankylosingspondylitisaswithadalimumab |